US Radioligand Therapy Market
US Radioligand Therapy RLT Market Research Report By Isotope (Fluorine โ 18, Gallium โ 68, Lutetium โ 177, Others), By Targeted Receptor (Prostate-specific Membrane Antigen (PSMA), Somatostatin Receptor (SSTR), Epidermal Growth Factor Receptor (EGFR), Others), By Indication (Prostate Cancer, Neuroendocrine Tumors (NETs), Breast Cancer, Others) and By End User (Hospitals & Clinics, Diagnostic Centers, Others) - Forecast to 2035
US Radioligand Therapy RLT Market Overview
As per MRFR analysis, the US Radioligand Therapy RLT Market Size was estimated at 1.69 (USD Billion) in 2023.The US Radioligand Therapy RLT Market Industry is expected to grow from 2(USD Billion) in 2024 ..